The Optispan Podcast with Matt Kaeberlein cover image

Rapamycin: The Worst Longevity Idea Ever Conceived? | 110

The Optispan Podcast with Matt Kaeberlein

00:00

Examining the Efficacy and Misinformation Surrounding Rapamycin Use

This chapter examines the promising effects of off-label rapamycin in treating periodontal disease and oral inflammation, supported by anecdotal evidence and animal research. The speaker urges the necessity of clinical trials for accurate human data and critiques misinformation surrounding rapamycin found online.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app